Oral fluoropyrimidine-induced severe hyperlipidemia

.blurhash-client-img { display: none !important; }

Open Access

|Apr 2018

Authors

Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey

Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey

Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey

Department of Internal Medicine, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey

Department of Endocrinology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey

Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey

Department of Medical Oncology, Faculty of Medicine, Karadeniz Technical University,, Trabzon, Turkey

DOI: https://doi.org/10.2478/abm-2010-0079 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415

Language: English

Page range: 627 - 630

Published on: Apr 13, 2018

In partnership with: Paradigm Publishing Services

Publication frequency: 6 issues per year

Keywords:

Related subjects:

© 2018 Bulent Yildiz, Halil Kavgaci, Evren Fidan, Erdal Gungor, Halil O. Ersoz, Feyyaz Ozdemir, Fazil Aydin, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.